Apple’s smartwatch line is set for a major leap forward next year.
According to DigiTimes, sales of the current Apple Watch lineup have already exceeded expectations by around 10%, and the company is preparing to raise the bar with the Apple Watch Series 11 and Watch Ultra 3.
The new models are expected to bring both hardware and software upgrades, along with a refreshed design. Industry insiders point to blood pressure tracking as one of the headline features. Rather than trying to replace medical devices, the watch will focus on spotting unusual patterns and sending timely alerts. Apple is also exploring non-invasive blood glucose monitoring-a feature long considered a ‘moonshot’ for wearables. While challenges like patents, regulations, and tech limitations remain, even small steps in this direction would be a big win for users and healthcare innovation overall.
Perhaps the most significant change is under the hood. Reports suggest that Apple will double the number of sensors in its upcoming models. Instead of depending so heavily on algorithmic guesswork, the devices will rely more on raw sensor data. That means more accuracy, better performance, and improved battery efficiency.
As for design, leaks hint at a major refresh, though specifics are still scarce. If true, Apple could be setting the stage for its most ambitious smartwatch update in years-moving the Apple Watch beyond fitness and lifestyle and deeper into serious health monitoring territory.